NinePoint Medical, Inc. Sustainability Profile
NinePoint Medical, Inc., headquartered in the United States, is a pioneering company in the medical technology industry, specialising in advanced imaging solutions for gastrointestinal applications. Founded in 2011, NinePoint has made significant strides in the development of its innovative products, particularly the NvisionVLE Imaging System, which offers real-time, high-resolution imaging for the early detection of cancerous lesions. With a focus on enhancing patient outcomes, NinePoint Medical stands out for its unique combination of optical coherence tomography and advanced imaging techniques. The company has established a strong market position, recognised for its commitment to improving diagnostic accuracy and procedural efficiency. As it continues to expand its operational reach, NinePoint Medical remains dedicated to transforming the landscape of gastrointestinal diagnostics through cutting-edge technology and a patient-centric approach.
DitchCarbon Score
How does NinePoint Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
NinePoint Medical, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
NinePoint Medical, Inc.'s reported carbon emissions
NinePoint Medical, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that NinePoint Medical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it will be essential for NinePoint Medical to consider developing and communicating its climate commitments to align with broader environmental goals.
How Carbon Intensive is NinePoint Medical, Inc.'s Industry?
How Carbon Intensive is NinePoint Medical, Inc.'s Location?
NinePoint Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
NinePoint Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Siemens Healthineers AG
SpectraScience, Inc.
C. R. Bard, Inc.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.